IP Library Granted Patent US 8,346,355
Granted Patent B2
US 8,346,355 · App. 13/269,350 · Granted Jan 1, 2013

Capacitor reformation method and apparatus

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,346,355
App. No.
13/269,350
Granted
Jan 1, 2013
Kind
B2
Abstract

A method of reforming a wet-tantalum capacitor includes providing a medical device comprising a wet-tantalum capacitor. The capacitor has a rated voltage and including a hydrated anodic deposit. The method further includes charging the capacitor to a voltage that is less than approximately seventy-five percent of the rated voltage and at least partially discharging the capacitor after the charging step. The charging step is performed at a sufficient voltage to dehydrate the anodic deposit while not significantly decreasing the service life of the capacitor.

Claims (31)

1. A method of reforming a capacitor comprising:

charging the capacitor to a voltage that is less than approximately seventy-five percent of a rated voltage for the capacitor, the capacitor being provided in an implantable medical device and including a hydrated anodic deposit prior to the charging step; and

at least partially discharging the capacitor after the charging step through at least one of a leakage current or a non-therapeutic load;

wherein the charging step is performed at a sufficient voltage to dehydrate the anodic deposit while not significantly decreasing the service life of the capacitor.

2. The method of claim 1 , wherein the capacitor comprises an anode that comprises a material selected from the group consisting of aluminum, niobium, zirconium, titanium, and alloys and oxides of aluminum, niobium, zirconium, and titanium.

3. The method of claim 1 , wherein the discharging step comprises discharging the capacitor through a leakage current.

4. The method of claim 1 , wherein the discharging step comprises discharging the capacitor through a non-therapeutic load.

5. The method of claim 1 , further comprising holding the capacitor at the voltage less than approximately seventy-five percent of the rated voltage for a time period greater than one hour.

6. The method of claim 5 , further comprising maintaining a charge level of the capacitor during the holding step using a top-off circuit.

7. The method of claim 1 , further comprising stopping the charging step upon initiation of a therapeutic discharge cycle.

8. The method of claim 1 , wherein the voltage less than approximately seventy-five percent of the rated voltage is less than approximately fifty percent of the rated voltage.

9. The method of claim 1 , wherein the anodic deposit is a soluble phosphate on an anode of the capacitor.

10. A method of reforming a capacitor comprising:

charging the capacitor to a voltage that is less than seventy-five percent of a rated voltage for a capacitor, wherein the capacitor comprises a material selected from the group consisting of aluminum, niobium, zirconium, titanium, and alloys and oxides of aluminum, niobium, zirconium, and titanium; and

after the charging step, discharging the capacitor through a resistance or a leakage current;

wherein the charging step comprises maintaining the capacitor at the voltage for a sufficient amount of time to dehydrate a deposit on an anode of the capacitor to reform the capacitor.

11. The method of claim 10 , wherein the charging step is carried out automatically.

12. The method of claim 10 , wherein the charging step comprises maintaining the capacitor at the voltage for a time period greater than one hour.

13. The method of claim 10 , wherein the charging step utilizes a top-off circuit to maintain a charge level of the capacitor.

14. The method of claim 10 , wherein the capacitor is provided in an implantable medical device and further comprising stopping the charging step upon initiation of a therapeutic discharge cycle.

15. The method of claim 10 , wherein the voltage is less than approximately fifty percent of the rated voltage.

16. A device comprising:

a processor;

a power source; and

at least one capacitor coupled to the power source,

wherein the processor carries out instructions to charge the capacitor to a voltage that is less than approximately seventy-five percent of a rated voltage for the capacitor and to discharge the at least one capacitor through leakage current or through a resistance such that an anodic deposit is dehydrated to reform the capacitor;

wherein the processor is configured to carry out the instructions in a manner that is intended to reform the capacitor at a relatively low voltage while not substantially adversely affecting the life of the capacitor.

17. The device of claim 16 , wherein the capacitor includes an anode formed of a material selected from the group consisting of aluminum, niobium, zirconium, titanium, and alloys and oxides of aluminum, niobium, zirconium, and titanium.

18. The device of claim 16 , wherein the processor is configured to maintain the voltage of the capacitor at a voltage that is less than approximately seventy-five percent of the rated voltage for the capacitor for more than one hour.

19. The device of claim 16 , wherein the processor is configured to maintain the voltage of the capacitor at a voltage that is less than approximately fifty percent of the rated voltage for the capacitor.

20. The device of claim 16 , wherein the device is selected from the group consisting of munitions, a photo flash, and an automated external defibrillator.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Nov 8, 2018
From: BANK OF AMERICA, N.A.
To: KEMET CORPORATION,; KEMET ELECTRONICS CORPORATION; KEMET BLUE POWDER CORPORATION
Reel/Frame 047450/0926 →
SECURITY AGREEMENT Recorded May 22, 2017
From: KEMET CORPORATION; KEMET ELECTRONICS CORPORATION; KEMET BLUE POWDER CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 042523/0639 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2012
From: NORTON, JOHN D.; MELODY, ANITA; KINARD, JOHN TONY
To: MEDTRONIC, INC.; KEMET ELECTRONICS CORPORATION
Reel/Frame 027593/0275 →